Contents
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Volume 3 - Number 2
Update on Current and Future Pharmacologic Therapy of COPD
, 3(2): 81 - 101L. Brandolini, M. Allegretti, S. Colagioia, R. Novellini, F. Colotta, R. Bertini and G. Melillo
DOI: 10.2174/1568014043355429
Chemokines and Persistent Inflammation in Rheumatoid Arthritis: Hunting for Therapeutic Targets
, 3(2): 103 - 117A. D. Filer, A. C. Burman, O. Haworth, G. Parsonage, M. Salmon and C. D. Buckley
DOI: 10.2174/1568014043355393
Recent Advances for Cell / Gene Therapy in Rheumatoid Arthritis
, 3(2): 119 - 138F. Apparailly, P. Plence, D. Noel and C. Jorgensen
DOI: 10.2174/1568014043355410
Quantitative Structure Activity Relationships (QSARs) on Lipoxygenase Inhibitors
, 3(2): 139 - 156Eleni Pontiki and Dimitra Hadjipavlou-Litina
DOI: 10.2174/1568014043355375
Pharmacological Inhibitors of Cysteinyl Leukotrienes Biosynthesis: Therapeutic Implications
, 3(2): 157 - 165L. Mastalerz, M. Sanak and A. Szczeklik
DOI: 10.2174/1568014043355384
The Basophil Granulocyte in Allergic Reactions: Experimental Models and their Use for the Identification of Drugs with Effects or Side Effects on Basophils
, 3(2): 167 - 180Lars K. Poulsen, Sha Quan, Claudia Krag, Michael H. Platzer and Per Stahl Skov
DOI: 10.2174/1568014043355401
Webmaster Contact: info@benthamscience.net